Shire sells cancer biz for $2.4bn
Shire has sold its oncology business to French firm Servier S.A.S as it looks to better align its long-term strategy.
Archives for April 17, 2018
GE launches modular bioprocessing facility for viral vector vaccines
GE Healthcare Life Sciences has launched a prefabricated, modular bioprocessing facility designed for the manufacture of viral vector-based therapeutics.